Related Experiment Video

Updated: Jun 11, 2026

Multimodality Diagnosis of Mesenteric Ischemia
05:07

Multimodality Diagnosis of Mesenteric Ischemia

Published on: July 21, 2023

Chronic atherosclerotic mesenteric ischemia (CMI)

Thomas Zeller1, Aljoscha Rastan, Sebastian Sixt

  • 1Herzzentrum Bad Krozingen, Bad Krozingen, Germany. thomas.zeller@herzzentrum.de

Vascular Medicine (London, England)
|June 30, 2010
PubMed

Insights

Chronic mesenteric ischemia (CMI) is a serious condition often caused by atherosclerosis affecting visceral arteries. Endovascular revascularization is now the preferred treatment over surgery for CMI.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Interventional Radiology

Background:

  • Chronic mesenteric ischemia (CMI) stems from atherosclerosis, external compression, or vasculitis, often involving multiple visceral arteries.
  • Symptomatic CMI is underdiagnosed, typically resulting from stenoses or occlusions in at least two of the three major mesenteric arteries.
  • Celiac artery compression syndrome is a distinct entity involving nerve compression and celiac trunk compromise.

Purpose of the Study:

  • To review the clinical aspects of chronic mesenteric ischemia.
  • To discuss current diagnostic and treatment practices for CMI.

Main Methods:

  • Review of clinical literature on chronic mesenteric ischemia.
  • Analysis of diagnostic modalities and therapeutic approaches.

Main Results:

  • Atherosclerotic CMI carries significant morbidity and mortality.
  • Endovascular revascularization has become the primary treatment modality, supplanting surgical revascularization in recent years.

Conclusions:

  • CMI diagnosis and management require a comprehensive understanding of its pathophysiology.
  • The shift towards endovascular techniques reflects advancements in treating visceral artery disease.

More Related Videos

Rodent Model of Intestinal Ischemia-Reperfusion Injury via Occlusion of the Superior Mesenteric Artery06:29

Rodent Model of Intestinal Ischemia-Reperfusion Injury via Occlusion of the Superior Mesenteric Artery

Published on: October 20, 2023

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...